Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
NEURO-HF: [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction (clinicaltrials.gov) - Oct 3, 2026 - P1 | N=18 | Not yet recruiting | Sponsor: Stony Brook University 
New P1 trial • Alzheimer's Disease • Cardiovascular • CNS Disorders • Cognitive Disorders • Congestive Heart Failure • Dementia • Heart Failure • Inflammation
http://clinicaltrials.gov/ct2/show/NCT07856043
 
Oct 3, 2026
 
Prev Next